183 related articles for article (PubMed ID: 38114968)
21. Fluoroquinolone-based antimicrobial prophylaxis in patients undergoing transrectal ultrasound-guided prostate biopsy.
Sieczkowski M; Gibas A; Bronk M; Matuszewski M
Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1815-21. PubMed ID: 26048634
[TBL] [Abstract][Full Text] [Related]
22. Fosfomycin vs. quinolone-based antibiotic prophylaxis for transrectal ultrasound-guided biopsy of the prostate: a systematic review and meta-analysis.
Noreikaite J; Jones P; Fitzpatrick J; Amitharaj R; Pietropaolo A; Vasdev N; Chadwick D; Somani BK; Rai BP
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):153-160. PubMed ID: 29487398
[TBL] [Abstract][Full Text] [Related]
23. "Targeted" prophylaxis: Impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy.
Singh P; Kumar A; Yadav S; Prakash L; Nayak B; Kumar R; Kapil A; Dogra PN
Investig Clin Urol; 2017 Sep; 58(5):365-370. PubMed ID: 28868509
[TBL] [Abstract][Full Text] [Related]
24. An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy.
Summers SJ; Patel DP; Hamilton BD; Presson AP; Fisher MA; Lowrance WT; Southwick AW
World J Urol; 2015 Dec; 33(12):2001-7. PubMed ID: 25935330
[TBL] [Abstract][Full Text] [Related]
25. Povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy are associated with reduced incidence of postoperative infectious complications.
Ryu JW; Jung SI; Ahn JH; Hwang EC; Yu HS; Kang TW; Kwon DD; Park K; Kim JW
Int Urol Nephrol; 2016 Nov; 48(11):1763-1770. PubMed ID: 27495324
[TBL] [Abstract][Full Text] [Related]
26. Fosfomycin trometamol vs ciprofloxacin for antibiotic prophylaxis before transrectal ultrasonography-guided prostate biopsy: A meta-analysis of clinical studies.
Freitas DMO; Moreira DM
Arab J Urol; 2019; 17(2):114-119. PubMed ID: 31285922
[No Abstract] [Full Text] [Related]
27. Effect of Augmented Antimicrobial Prophylaxis and Rectal Swab Culture-guided Targeted Prophylaxis on the Risk of Sepsis Following Transrectal Prostate Biopsy.
Hadjipavlou M; Eragat M; Kenny C; Pantelidou M; Mulhem W; Wood C; Dall'Antonia M; Hammadeh MY
Eur Urol Focus; 2020 Jan; 6(1):95-101. PubMed ID: 31928632
[TBL] [Abstract][Full Text] [Related]
28. Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study.
Knaapila J; Kallio H; Hakanen AJ; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Gunell M; Boström PJ
BJU Int; 2018 Aug; 122(2):203-210. PubMed ID: 29533507
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and Safety of Two Fosfomycin Regimens as Antimicrobial Prophylaxis for Transrectal Prostate Biopsy: A Randomised Study.
D'Elia C; Mian C; Hanspeter E; Ladurner C; Palermo SM; Pycha S; Saleh O; Cai T; Spoladore G; Kafka M; Pycha A; Trenti E
Urol Int; 2019; 103(4):433-438. PubMed ID: 31614361
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Complication Rates with Antibiotic Prophylaxis with Cefpodoxime Versus Fluoroquinolones After Transrectal Prostate Biopsy.
Wenzel M; Welte MN; Theissen LH; Wittler C; Hoeh B; Humke C; Preisser F; Würnschimmel C; Tilki D; Graefen M; Roos FC; Becker A; Karakiewicz PI; Chun FKH; Kluth LA; Mandel P
Eur Urol Focus; 2021 Sep; 7(5):980-986. PubMed ID: 33358884
[TBL] [Abstract][Full Text] [Related]
31. [Optimization of prevention of infectious complications during prostate biopsy].
Kolontarev K B; Stroganov R V; Pushkar D Y
Urologiia; 2023 Dec; (6):128-132. PubMed ID: 38156696
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study.
Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW
Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and significance of fluoroquinolone-resistant bacteria carriage in patients undergoing transrectal ultrasound prostate biopsy.
Hasanzadeh A; Pourmand MR; Alizadeh A; Pourmand G
Urol J; 2017 May; 14(3):3085-3090. PubMed ID: 28537050
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin.
Lista F; Redondo C; Meilán E; García-Tello A; Ramón de Fata F; Angulo JC
Actas Urol Esp; 2014; 38(6):391-6. PubMed ID: 24775812
[TBL] [Abstract][Full Text] [Related]
35. Fosfomycin antimicrobial prophylaxis for transrectal ultrasound-guided biopsy of the prostate: A prospective randomised study.
Fahmy AM; Kotb A; Youssif TA; Abdeldiam H; Algebaly O; Elabbady A
Arab J Urol; 2016 Sep; 14(3):228-33. PubMed ID: 27547466
[TBL] [Abstract][Full Text] [Related]
36. Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacteria and treatment patterns from a 4-year prospective study.
Campeggi A; Ouzaid I; Xylinas E; Lesprit P; Hoznek A; Vordos D; Abbou CC; Salomon L; de la Taille A
Int J Urol; 2014 Feb; 21(2):152-5. PubMed ID: 23906113
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Fluoroquinolones and Other Antibiotic Prophylaxis Regimens for Preventing Complications in Patients Undergoing Transrectal Prostate Biopsy.
Tulone G; Giannone S; Mannone P; Tognarelli A; Di Vico T; Giaimo R; Zucchi A; Rossanese M; Abrate A; Pavan N; Claps F; Ficarra V; Bartoletti R; Simonato A
Antibiotics (Basel); 2022 Mar; 11(3):. PubMed ID: 35326878
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Different Rectal Cleansing Methods for Reducing Post-Procedural Infectious Complications After Transrectal Ultrasound-Guided Prostate Biopsy.
Lee JE; Shin SS; Kang TW; Kim JW; Heo SH; Jeong YY
Urol J; 2020 Jan; 17(1):36-41. PubMed ID: 30882162
[TBL] [Abstract][Full Text] [Related]
40. Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli.
Williamson DA; Barrett LK; Rogers BA; Freeman JT; Hadway P; Paterson DL
Clin Infect Dis; 2013 Jul; 57(2):267-74. PubMed ID: 23532481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
